The Kitasato Institute, Tokyo, Japan
Vaccines Japan is not using ivermectin instead of vaccines to trea t Covid-19 16 November 2021 What was claimed Japan stopped its vaccine rollout, treated
Proc Jpn Acad Sers B Phys Biol Sci
A physician-led clinical study by Japan's Kitasato University on ivermectin as a Covid-19 treatment is ongoing, but public broadcaster NHK reported on August 23 that
neck or back pain, seizure (convulsions); or
3 A recent RCT from Iran found a dramatic reduction in mortality with ivermectin use
Ivermectin is a medication that's been around for decades, and it's been a miracle drug against parasites
Ivermectin is an antiparasitic drug that is well established for use in animals and people
Despite this promise, the antiviral activity of ivermectin has not been consistently proven in vivo
In addition to IVM, the current avermectin family members include selamectin, doramectin and moxidectin [, , , ] (Fig
In this article, we would like to highlight on the rationality of using ivermectin for COVID-19 with evidence from clinical studies conducted in different parts of the world
Lindquist M The antiviral effects of ivermectin on RNA viruses COVID-19
The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals
On Monday, Japanese trading and pharmaceutical company Kowa Co
The Indian Council of Medical Research (ICMR) and the National Task Force on Covid-19 have dropped the use of Ivermectin and Hydroxychloroquine (HCQ) drugs from their revised guidelines for the treatment of the infection
An article online falsely claims Japanese authorities have abandoned the rollout of COVID-19 vaccines, instead choosing to rely on ivermectin, an anti-parasitic medication